Addressing high cervical cancer rates in the Rio Grande Valley along the Texas-Mexico border: a community-based initiative focused on education, patient navigation, and medical provider training/telementoring.


Journal

Perspectives in public health
ISSN: 1757-9147
Titre abrégé: Perspect Public Health
Pays: United States
ID NLM: 101499631

Informations de publication

Date de publication:
Jan 2023
Historique:
pubmed: 17 6 2021
medline: 27 1 2023
entrez: 16 6 2021
Statut: ppublish

Résumé

Cervical cancer incidence and mortality rates are approximately 55% higher in the Rio Grande Valley (RGV) along the Texas-Mexico border compared with the average rates in the US. Our aim was to improve cervical cancer prevention efforts in the RGV through a comprehensive multilevel intervention initiative focused on community education, patient navigation, and training of local providers. We initiated a program in the RGV which consisted of (1) community education, (2) patient navigation, and (3) a training/mentoring program for local medical providers including hands-on training courses coupled with telementoring using From November 2014 to October 2018, 14,846 women underwent cervical cancer screening. A total of 2030 (13.7%) women underwent colposcopy for abnormal results (179% increase over baseline) and 453 women underwent loop electrosurgical excision procedures (LEEPs) for treatment of cervical dysplasia. Invasive cancer was diagnosed in 39 women who were navigated to a gynecologic oncologist for treatment. Seven local medical providers were trained to perform colposcopy and/or LEEP. Project ECHO telementoring videoconferences were held every 2 weeks for a total 101 sessions with an average of 22 participants per session and a total of 180 patient cases presented and discussed. Our program led to a large number of women undergoing diagnosis and treatment of cervical dysplasia in the RGV. If sustained, we anticipate these efforts will decrease cervical cancer rates in the region. The program is currently being expanded to additional underserved areas of Texas and globally to low- and middle-income countries.

Identifiants

pubmed: 34130548
doi: 10.1177/1757913921994610
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

22-28

Auteurs

M P Salcedo (MP)

The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Federal University of Health Sciences of Porto Alegre (UFCSPA)/Irmandade Santa Casa de Misericordia de Porto Alegre, Porto Alegre, Brazil.

R Gowen (R)

Su Clínica, Brownsville, TX, USA.

A M Rodriguez (AM)

The University of Texas Medical Branch, Galveston, TX, USA.

S Fisher-Hoch (S)

School of Public Health, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX, USA.

M Daheri (M)

School of Public Health, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX, USA.

L Guerra (L)

Su Clínica, Brownsville, TX, USA.

P A Toscano (PA)

UTHealth McGovern Medical School, Houston, TX, USA.

M Gasca (M)

School of Public Health, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX, USA.

J Morales (J)

School of Public Health, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX, USA.

F E Reyna-Rodriguez (FE)

UTHealth McGovern Medical School, Houston, TX, USA.

B Cavazos (B)

Su Clínica, Brownsville, TX, USA.

E Marin (E)

Su Clínica, Brownsville, TX, USA.

C Perez (C)

Su Clínica, Brownsville, TX, USA.

M Guerra (M)

The University of Texas Medical Branch, Galveston, TX, USA.

A Milbourne (A)

The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

M L Varon (ML)

The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

B Reininger (B)

School of Public Health, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX, USA.

M E Fernandez (ME)

School of Public Health, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX, USA.

T Ogburn (T)

The University of Texas Rio Grande Valley Medical School, Edinburg, TX, USA.

P E Castle (PE)

National Cancer Institute, National Institutes of Health, Rockville, MD, USA.

J McCormick (J)

School of Public Health, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX, USA.

E Baker (E)

The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

E Hawk (E)

The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

K M Schmeler (KM)

Department of Gynecologic Oncology & Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Unit 1362, 1515 Holcombe Boulevard, Houston, TX 77030, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH